Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon

Pfizer stops clinical trial development program for PCSK9 inhibitor

After finding issues in clinical trials and assessing the current market, Pfizer Inc. announced Nov. 1 that it was discontinuing development of bococizumab, its investigational proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor.

TAVR sales increase 39% for Edwards Lifesciences during 3Q

During the third quarter of 2016, Edwards Lifesciences’ revenue increased 20.1 percent to $739.4 million and its GAAP earnings per share increased 20.4 percent to $0.65 per share compared with the same time period last year. Meanwhile, adjusted earnings per share increased 25.9 percent to $0.68 per share.

Pediatric interventional cardiology market anticipates 9 percent growth by 2022

Advancements in technology are driving market growth.

Thumbnail

Conferencing with the Cardiologist: Virtual Visits Bring Patients + Providers Together Between Scheduled Appointments

Cardiologists are leveraging telemedicine to be in two places at once.

Thumbnail

Give + Take: Pharma, Payers Forge Risk-sharing Deals for New Heart Drugs

Performance-based risk-sharing deals allow payers to hedge their bets with new drugs while helping pharmaceutical companies grow market share.

Boston Scientific beats quarterly revenue projections, increases guidance for full year

For the third quarter of 2016, Boston Scientific’s revenue increased 11 percent to $2.11 billion compared with the same period last year. The company announced in an Oct. 26 news release that it beat its guidance, which was $2.04 billion to $2.09 billion.

Thumbnail

CMS has higher penalties for readmissions than for deaths

If the Centers for Medicare & Medicaid Services (CMS) weighted 30-day readmissions and mortality equally, financial penalties in 2014 for U.S. hospitals would have substantially changed, according to an analysis of publicly available hospital data.

Thumbnail

Aggressive blood pressure target may make financial sense for high-risk patients

A recent analysis of that study suggests that intensive blood pressure management may be cost-effective for adults who are at least 50 years old, have hypertension but do not have diabetes and are at high risk for cardiovascular disease.

Displaying 1137 - 1144 of 1706

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.